1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, June 2016 (p2)

Biological Therapy Analysis & Statistics, June 2016 (p2)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

31-60 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Interleukin 15 (IL15) - Pipeline Review, H1 2016

Interleukin 15 (IL15) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 15 (IL15) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : World, United States
Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology
  • Countries : United States
Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Japan
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biopharmaceutical, Cancer, Pathology, Biotechnology
  • Countries : United States
Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Cancer, Pathology, Therapy, Biotechnology, Biopharmaceutical
  • Countries : United States, World
Interleukin 13 (IL13) - Pipeline Review, H1 2016

Interleukin 13 (IL13) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Therapy, Pathology, Biological Therapy, Biopharmaceutical, Chronic Disease, Biotechnology
  • Countries : United States
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, ...

  • Industries : Biological Therapy, Therapy, Biopharmaceutical, Biotechnology, Cancer, Pathology
  • Countries : United States, World
Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucin 1 (MUC-1 or Breast Carcinoma-Associated ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Biotechnology, Pharmaceutical
  • Countries : World, United States
Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology, Biological Therapy
  • Countries : United States
HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016’, provides in depth analysis on HIV-1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Facto ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States, World
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Cancer, Pathology, Pharmaceutical
  • Countries : United States
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Biological Therapy, Therapy, Biotechnology, Pathology, Cancer
  • Countries : United States
Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 ...

  • Industries : Cancer, Therapy, Pathology, Biotechnology, Oncology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Biological Therapy, Pathology, Biotechnology, Therapy
  • Countries : United States
Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Tumor Necrosis Factor Recepto ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
  • Countries : United States
Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016

Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast ...

  • Industries : Therapy, Biological Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology
  • Countries : United States, World
C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - ...

  • Industries : Biological Therapy, Therapy, Cancer, Pharmaceutical, Pathology
  • Countries : Japan, World
C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine ...

  • Industries : Therapy, Biological Therapy
  • Countries : United States, World, Italy
C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine ...

  • Industries : Biological Therapy
  • Countries : United States, World
C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil ...

  • Industries : Biopharmaceutical, Chronic Disease, Biological Therapy, Pharmaceutical, Pathology
  • Countries : World
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin-2 Receptor Subunit Alpha (IL-2 Receptor Subunit Alpha ...

  • Industries : Biopharmaceutical, Biological Therapy, Therapy, Biotechnology
  • Countries : World, United States
Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016

Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

  • $ 2 995
  • Industry report
  • July 2016
  • by GBI Research

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell Therapies - Global Trends in the Competitive, Technological and ...

  • Industries : Biological Therapy
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2 995
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Biological Therapy, Pathology, Biotechnology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
About 1 900 reports

Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in the UK

  • August 2016
    15 pages
  • Hormone  

    Therapy  

    Cytokine  

  • United Kingdom  

View report >

Dna Industry In Japan

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.